Home » Newsletters » BioWorld

BioWorld

April 6, 1994

View Archived Issues

IMMUNEX FILES NEW PLA FOR LEUKINE

BRITISH BIOTECH SHARES BUCK THE TREND

VIAGENE GETS $10M BOOST FROM GREEN CROSS

CORRECTION

SHEFFIELD TO START TESTING LIPOSOME-CD4

SYNTRO GETS OK FOR FIELD TRIAL

GENENTECH'S PHASE II RESULTS FOR PULMOZYME LOOK POSITIVE

GENENTECH, PCS HEALTH SYSTEMS LINK UP

APHTON RAISES $10.4 MILLION

NIH INVITES LICENSEES FOR AIDS DRUG FROM BORNEO TREE

ARCTURUS FILES FOR IPO

ALZHEIMER'S IMPROVES WITH COGNEX

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...